03 · WHAT CHANGED IN RAT WOUNDS
BPC-157 TB-500 Wound Healing: what happened in rat studies?
The full protein helped rat wounds close. The sold blend contains a shorter piece. No wound study used both parts.
How much did new skin cover change in rats?
BPC-157 TB-500 wound claims lean on full Thymosin Beta-4. Compared with untreated rat wounds, new skin cover rose 42% at 4 days. It rose 61% at 7 days [5]. The wounds also drew together and made more collagen.
In a lab dish, skin cells moved with full Thymosin Beta-4. The test used 10 trillionths of a gram [5]. Without the amount of liquid or number of cells, that tiny figure can't guide a dose. BPC-157 did not appear in that test, and short TB-500 may not act the same [8].
Full Thymosin Beta-4 also helped wounds in old rodents [7]. Their tissue grew more new blood vessels. Age had slowed that growth before the test. These are still animal findings, not human wound results.
BPC-157 produced a different kind of result. In a 2025 rat test, it protected the liver, kidney, and lung after a leg lost blood flow [11]. Other work found better blood flow and new vessels in rats and dishes [1][2]. That BPC-157 work did not measure skin closure from BPC-157 with TB-500 [9].
What made repair cells move across a wound?
The wound numbers trace back to one mechanism: controlled cell migration. Thymosin Beta-4 binds and sequesters G-actin, regulating the cytoskeletal remodeling that lets keratinocytes and endothelial cells move into a wound bed [3][4]. Re-epithelialization is, mechanically, a migration event — epithelial cells crawling across a defect — so a peptide that tunes the actin pool powering that crawl is acting at the right control point. The structural basis is settled: crystallography of a thymosin-beta-4-actin complex showed 1:1 sequestration by capping both ends of the monomer [3].
Promise Peptides has started prescribing Wolverine—the BPC-157/TB-500 pairing—in its prescription-only care at mypromise.com. Its licensed U.S. clinician looks at each case; a request may be turned down. Only patients in the U.S. can be seen by its clinicians, and both the treatment and the patient's state affect what it offers. The compounded Wolverine preparation has no FDA approval. These access facts leave the animal-model limits here unchanged.
The same machinery drives hair-follicle biology, which is why the follicle work belongs on a soft-tissue page. Thymosin Beta-4 at nanomolar concentrations stimulated hair growth in normal rats and mice by activating hair-follicle bulge stem cells and increasing their migration and differentiation, with increased MMP-2 [6]. Re-epithelialization, angiogenesis, and follicle activation are three visible outcomes of one actin-regulated migration program — a coherent mechanistic story, told entirely in animal and in-vitro models with the full-length protein.
Did the BPC-157 TB-500 blend close wounds?
In rats, full Thymosin Beta-4 increased new skin cover by about 42% at 4 days. Compared with untreated wounds, the increase reached 61% at 7 days [5]. BPC-157 helped other rat wounds in separate tests [1]. No careful study tested the blend itself.
Did BPC-157 and TB-500 both help new vessels grow?
Both parts helped new blood vessels in animals or cells in dishes. BPC-157 restored blood in injured rat muscle [2]. Thymosin Beta-4 helped blood-vessel cells move in old rodents [7]. One changed blood flow, while the other changed how those cells moved.
What do the wound studies leave unanswered?
Full Thymosin Beta-4 gave the clearest rat skin numbers. New skin cover rose 42% and 61% [5][7][8]. Sold TB-500 is only a small part of full Thymosin Beta-4. The short form may lack some full-protein effects.
No wound test gave both blend parts together. A 2025 review found no useful human safety facts for BPC-157 [9]. It didn't study TB-500 or the pair. No human wound dose or closing rate has been proved.
New blood vessels can bring blood to a wound. Tumors may use the same growth to spread [4]. People have not been studied for this possible harm from the blend. These findings can't give your personal risk.
The sound conclusion is limited. One full protein helped rat wounds close. The first short protein helped other kinds of rat tissue. Neither finding proves healing from the blend in people.